One World Cannabis Ltd.
One World Cannabis Ltd., a wholly owned Israeli subsidiary of OWC Pharmaceutical Research Corp. (OTCQB:OWCP), is focused on discovering, developing and commercializing cannabis-based novel therapeutics products and treatments specifically designed for several medical conditions, starting with multiple myeloma, psoriasis, fibromyalgia, PTSD (post-traumatic stress disorder) and migraines.
One World Cannabis is a young company that, despite its youth, is already playing a part in making history.
The expert team delivers years of proven practices in diverse disciplines, including medical science and regulatory affairs, as well as extensive cannabis-related issues experience.
One World Cannabis aspires to become one of the world’s leading players in the hyper-growing market of medical cannabis by providing the missing yet prerequisite element of scientific validity for cannabis based products.
The Company is committed to and the highest standards of integrity and ethics in proposing, conducting and reporting research. All its investigations and researches are conducted at the facilities of leading Israeli medical centers, as well as at the labs of the R&D pharmaceutical companies we contracted with. The Company adheres to all the necessary regulatory requirements, including submitting its research protocols to Ethics Committee (IRB) approval.
When it comes to medical cannabis, OWC believes in science instead of mythology.
We aim to produce pharmaceutical-grade cannabis-based products and treatments that are:-
- Standardized in composition, formulation and dose;
- Administered by means of the appropriate and efficient innovative delivery systems; and –
- Tested in properly controlled pre-clinical and clinical studies.
We believe that its planned products will provide physicians with the ability to control and administrate optimal dosage, and to replace the common usage of medical cannabis today, which is not acceptable by scientists and physicians, such as smoking, edibles and oil extracts with no substantial dosage control.
We also believe that our planned products will provide patients with the absolute assurance that they are purchasing and taking products that are clinically tested, safe, efficient and consistent.One World Cannabis believes that the complexity of the medical cannabis programs has created a demand for consulting and advisory services in differen…
Isiah Thomas Announces One World Pharma’s First THC Harvest
LAS VEGAS, NV, Aug. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that the Company has completed its first THC harvest. The harvest utilized a THC quota granted to One World Pharma by the Colombian government.
OWP received its THC quota in December of 2019 and planted the psychoactive seeds in February of this year. The Company is one of only seventeen companies of the 246 licensed operators in Colombia to be able to register THC strains. The crops were harvested, dried, and analyzed for authenticity in July.
The harvest initiates the process of the Company authenticating its genetics and protecting its intellectual property. Most importantly, the successful completion of a full THC harvest allows the Company to now approach companies in legal countries which allow THC for medicinal use or pharmaceutical companies in need of THC ingredients for research and product development.
“This first harvest is a milestone of significant importance for One World Pharma,” stated Isiah Thomas, CEO, One World Pharma. “It is also a strong testament to our collaborative relationship with the Colombian government and its highly skilled indigenous population.”
“With this crop fully harvested and authenticated, we are now well-positioned to grow crops at scale in Latin America. This is the next and perhaps most important step in our ultimate goal to sell the best raw cannabis ingredients around the world,” added Thomas.
About One World Pharma
Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.
One World Pharma Investor Relations & Financial Media
Information about Forward-Looking StatementsLAS VEGAS, NV, Aug. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play… ]]>